XML 46 R17.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Stockholders' Equity | 12 Months Ended
--- | ---
Jun. 30, 2024
Stockholders' Equity |
Stockholders' Equity | Note 11. Stockholders’ Equity Common Stock As of June 30, 2024, the Company had 33,339,535 shares of common stock outstanding. The Company began paying quarterly cash dividends on common stock in December 2013. As of June 30, 2024, the Company has cumulatively paid over $118.4 million in cash dividends. The Company paid dividends of $16.0 million and $16.1 million to its common stockholders during the years ended June 30, 2024 and 2023, respectively. The following table reflects the dividends paid per share within the respective quarterly periods: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Fiscal Year
​ |  | 2024 |  | 2023
Fourth quarter ended June 30, | ​ | $ | 0.12 | ​ | $ | 0.12
Third quarter ended March 31, | ​ | ​ | 0.12 | ​ | ​ | 0.12
Second quarter ended December 31, | ​ | ​ | 0.12 | ​ | ​ | 0.12
First quarter ended September 30, | ​ | ​ | 0.12 | ​ | ​ | 0.12
​ On September 9, 2024, Evolution’s Board of Directors approved and declared a quarterly dividend of $0.12 per common share payable September 30, 2024. Refer to Note 14, “Subsequent Events,” for a further discussion. ​ On September 8, 2022, the Board of Directors approved a share repurchase program, under which the Company is authorized to repurchase up to $25.0 million of its common stock in the open market through December 31, 2024. The Company intends to fund repurchases from working capital and cash provided by operating activities. The Board of Directors along with the management team believe that a share repurchase program is complimentary to the existing dividend policy and is a tax efficient means to further improve shareholder return. The shares may be repurchased from time to time in open market transactions, through privately negotiated transactions or by other means in accordance with federal securities laws. The timing, as well as the number and value of shares repurchased under the program, will depend on a variety of factors, including management’s assessment of the intrinsic value of the Company’s shares, the market price of the Company’s common stock, the Company’s capital needs and resources, general market and economic conditions, and applicable legal requirements. The value of shares authorized for repurchase by the Company's Board of Directors does not require the Company to repurchase such shares or guarantee that such shares will be repurchased, and the program may be suspended, modified, or discontinued at any time without prior notice. As of June 30, 2024, a total of 0.8 million shares of the Company’s common stock have been repurchased under the plan at a total cost of approximately $4.6 million, including incremental direct transaction costs. ​ In December 2022, the Company entered into a Rule 10b5-1 plan that authorized a broker to repurchase shares in the open market subject to pre-defined limitations on trading volume and price. The plan included a 30-day cooling off period that did not allow repurchases to commence until January 2023. The plan was effective until June 30, 2023 and had a maximum authorized amount of $5.0 million over that period. During the year ended June 30, 2023, 0.6 million shares of the Company’s common stock were repurchased under the plan at a total cost of approximately $3.9 million, including incremental direct transaction costs. These treasury shares were subsequently cancelled. ​ In November 2023, the Company entered into a Rule 10b5-1 plan that authorized a broker to repurchase shares in the open market subject to pre-defined limitations on trading volume and price. The plan was effective until June 30, 2024 and had a maximum authorized amount of $0.8 million over that period. During the year ended June 30, 2024, 0.1 million shares of the Company’s common stock were repurchased under the plan at a total cost of approximately $0.8 million, including incremental direct transaction costs. These treasury shares were subsequently cancelled. ​ During the years ended June 30, 2024 and 2023, the Company acquired treasury stock upon the ordinary course of scheduled vestings of employee stock-based awards to fund payroll tax withholding obligations. These treasury shares were subsequently cancelled. Such shares were valued at fair market value on the date of vesting. The following table summarizes all treasury stock purchases in the years ended June 30, 2024 and 2023 (in thousands, except per share amounts): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Years Ended June 30,
​ |  | 2024 | ​ | 2023
Number of treasury shares acquired(1) | ​ | ​ | 202 | ​ | ​ | 673
Average cost per share(1) | ​ | $ | 5.66 | ​ | $ | 6.20
Total cost of treasury shares acquired | ​ | $ | 1,144 | ​ | $ | 4,170
(1) | For the year ended June 30, 2024, includes 140,672 shares repurchased under the Company’s share repurchase program for a weighted average price of $5.33 per share. For the year ended June 30, 2023, includes 633,789 shares repurchased under the Company’s share repurchase program for a weighted average price of $6.07 per share.
​ Expected Tax Treatment of Dividends For the fiscal year ended June 30, 2023, all common stock dividends for that fiscal year were treated for tax purposes as qualified dividend income to the recipients. Based on its current projections for the fiscal year ended June 30, 2024, the Company expects all common stock dividends for such period to be treated as qualified dividend income to the recipients. Stock-Based Incentive Plan The Evolution Petroleum Corporation 2016 Equity Incentive Plan (as amended the “2016 Plan”), authorizes the issuance of 3.6 million shares of common stock prior to its expiration on December 8, 2026. Incentives under the 2016 Plan may be granted to employees, directors, and consultants of the Company in any one or a combination of the following forms: incentive stock options and non-statutory stock options, stock appreciation rights, restricted stock awards and restricted stock unit awards, performance share awards, performance cash awards, and other forms of incentives valued in whole or in part by reference to, or otherwise based on, the Company’s common stock, including its appreciation in value. As of June 30, 2024 and 2023, approximately 0.9 million shares and 1.3 million shares, respectively, remained available for grant under the 2016 Plan. The Company estimates the fair value of stock-based compensation awards on the grant date to provide the basis for future compensation expense. For the years ended June 30, 2024, and 2023, the Company recognized $2.1 million and $1.6 million, respectively, related to stock-based compensation expense recorded as a component of “General and administrative expenses” on the consolidated statements of operations. Time-Vested Restricted Stock Awards Time-vested restricted stock awards contain service-based vesting conditions and expire after a maximum of four years from the date of grant if unvested. The common shares underlying these awards are issued on the date of grant and participate in dividends paid by the Company. These service-based awards vest with continuous employment by the Company, generally in annual installments over terms of three to four years. Awards to the Company’s directors generally have one-year cliff vesting. For such awards, grant date fair value is based on market value of the Company’s common stock at the time of grant. This value is then amortized ratably over the service period. Previously recognized amortization expense subsequent to the last vesting date of an award is reversed in the event that the holder has no longer rendered service to the Company resulting in forfeiture of the award. Performance-Based Restricted Stock Awards and Performance-Based Contingent Stock Units Performance-based restricted stock awards and performance-based contingent stock units contain market-based vesting conditions based on the price of the Company’s common stock, the intrinsic value indexed solely to its common stock or the intrinsic value indexed to its common stock compared to the performance of the common stock of its peers. The common shares underlying the Company’s performance-based restricted stock awards are issued on the date of grant and participate in dividends paid by the Company and expire after a maximum of four years from the date of grant if unvested. Performance-based contingent share units do not participate in dividends and shares are only issued in part or in full upon the attainment of vesting conditions, generally have a lower probability of achievement and expire after a maximum of four years from the date of grant if unvested. Shares underlying performance-based contingent share units are reserved from the 2016 Plan. Performance-based restricted stock awards and contingent restricted stock units are valued using a Monte Carlo simulation and geometric Brownian motion techniques applied to the historical volatility of the Company’s total stock return compared to the historical volatilities of other companies or indices to which the Company compares its performance and/or the Company’s absolute total stock return. For certain awards, this Monte Carlo simulation also provides an expected vesting term. Stock-based compensation is recognized ratably over the expected vesting period, so long as the award holder remains an employee of the Company. Previously recognized compensation expense is only reversed for the awards with market-based vesting conditions if the requisite service period is not rendered by the holder resulting in forfeiture of the award or as a result of regulatory required clawback. Vesting of grants with performance-based vesting conditions is dependent on the future price of the Company’s common stock. Such awards vest in part or in full if the trailing total returns on the Company’s common stock for a specified three-year period exceed the corresponding total returns of various quartiles of indices consisting of peer companies or, in some cases, vest when the average of the Company’s closing common stock price over a defined measurement period meets or exceeds a required common stock price. For performance-based awards granted during the years ended June 30, 2024 and 2023, the assumptions used in the Monte Carlo simulation valuations were as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Years Ended June 30,
​ |  | 2024 |  | 2023
Weighted average fair value of performance-based awards granted | ​ | $ | 3.58 | ​ | $ | 6.52
Risk-free interest rate | ​ | ​ | 4.87% | ​ | ​ | 3.91% to 4.51%
Expected term in years | ​ | ​ | 2.77 | ​ | ​ | 2.36 to 2.78
Expected volatility | ​ | ​ | 55.0% | ​ | ​ | 56.5% to 70.9%
Dividend yield | ​ | ​ | 7.4% | ​ | ​ | 6.1% to 7.8%
​ Unvested restricted stock awards as of June 30, 2024 consisted of the following: ​
​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted
​ | ​ | Number of | ​ | Average
​ | ​ | Restricted | ​ | Grant-Date
Award Type |  | Shares |  | Fair Value
Time-vested awards | ​ | 395,104 | ​ | $ | 6.57
Performance-based awards | ​ | 233,407 | ​ | ​ | 5.87
Unvested at June 30, 2024 | ​ | 628,511 | ​ | $ | 6.31
​ The following table sets forth the restricted stock award transactions for the years ended June 30, 2024 and 2023: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Weighted | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted | ​ | Unamortized | ​ | Average | ​ | ​ | ​
​ | ​ | Number of | ​ | Average | ​ | Compensation | ​ | Remaining | ​ | Aggregate Intrinsic
​ | ​ | Restricted | ​ | Grant-Date | ​ | Expense | ​ | Amortization | ​ | Value (1)
​ |  | Shares |  | Fair Value |  | (In thousands) |  | Period (Years) |  | (In thousands)
Unvested at June 30, 2022 | ​ | 341,211 | ​ | $ | 4.54 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Time-vested shares granted | ​ | 376,015 | ​ | ​ | 7.18 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Performance-based shares granted | ​ | 100,239 | ​ | ​ | 7.39 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Vested | ​ | (196,431) | ​ | ​ | 4.91 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Forfeited | ​ | (25,620) | ​ | ​ | 6.51 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Unvested at June 30, 2023 | ​ | 595,414 | ​ | $ | 6.48 | ​ | $ | 2,827 | ​ | 2.4 | ​ | $ | 4,805
Time-vested shares granted | ​ | 157,692 | ​ | ​ | 6.22 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Performance-based shares granted | ​ | 136,315 | ​ | ​ | 4.80 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Vested | ​ | (260,910) | ​ | ​ | 5.85 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Unvested at June 30, 2024 | ​ | 628,511 | ​ | $ | 6.31 | ​ | $ | 2,492 | ​ | 1.8 | ​ | $ | 3,312
(1) | The intrinsic value of restricted stock was calculated as the closing market price on June 30, 2024 and 2023 of the underlying stock multiplied by the number of restricted shares that would be issuable. The total fair value of shares vested was $1.6 million and $1.4 million for the years ended June 30, 2024 and 2023, respectively.
The following table sets forth contingent restricted stock unit transactions for the years ended June 30, 2024 and 2023: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Weighted | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Unamortized | ​ | Average | ​ | ​ | ​
​ | ​ | Number of | ​ | Weighted Average | ​ | Compensation | ​ | Remaining | ​ | Aggregate Intrinsic
​ | ​ | Restricted | ​ | Grant-Date | ​ | Expense | ​ | Amortization | ​ | Value (1)
|  | Stock Units |  | Fair Value |  | (In thousands) |  | Period (Years) |  | (In thousands)
Unvested at June 30, 2022 | ​ | 50,062 | ​ | $ | 2.21 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Performance-based awards granted | ​ | 50,123 | ​ | ​ | 4.79 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Forfeited | ​ | (3,787) | ​ | ​ | 3.69 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Unvested at June 30, 2023 | ​ | 96,398 | ​ | $ | 3.49 | ​ | $ | 195 | ​ | 1.9 | ​ | $ | 778
Performance-based awards granted | ​ | 102,239 | ​ | ​ | 1.95 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Expired | ​ | (47,849) | ​ | ​ | 2.19 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Unvested at June 30, 2024 | ​ | 150,788 | ​ | $ | 2.86 | ​ | $ | 230 | ​ | 1.6 | ​ | $ | 795
(1) | The intrinsic value of contingent restricted stock units was calculated as the closing market price on June 30, 2024 and 2023 of the underlying stock multiplied by the number of restricted shares that would be issuable.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration